Sunesis Pharmaceuticals
Region | Nordamerika |
ISIN | US8673288747 |
Sektor | Biotechnologie |
Website | https://www.sunesis.com/ |
Sunesis is a clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics. With a passion to advance novel drugs, we are inspired to make a difference in cancer patients' lives.
Titel | Autor | Datum |
---|---|---|
Risikoarmes "Peak Play" mit Multibagger-Potenzial
|
sharedeals | vor über 4 Jahren |
Titel | Datum |
---|---|
MISC could potentially pay out higher dividends starting 2025 - Maybank | vor ungefähr einem Monat |
MISC tied to $312M HD Hyundai deal for 'world's largest' ethane carriers | vor ungefähr 2 Monaten |
MISC secures long-term contracts for two ethane carriers from Thailand's PTT | vor ungefähr 2 Monaten |
Analysts upgrade MISC amid share price weakness, earnings growth, dividend yield | vor ungefähr 2 Monaten |
Petronas Chemicals, Petronas Gas, MISC, Malakoff, Sports Toto, Parkson, Paramount, Eco World International, Mi Technovation, CSC Steel an... | vor ungefähr 2 Monaten |
Diese Aktien könnten Dich auch interessieren | |
---|---|
Suedzucker (1 Artikel) | |
Stockholm IT Ventures AB (1 Artikel) | |
Tahoe Resources (1 Artikel) | |
Telit Communications (3 Artikel) | |
Alle anzeigen |